-+ 0.00%
-+ 0.00%
-+ 0.00%

INHIBRX BIOSCIENCES INC - INBRX-106 PLUS PEMBROLIZUMAB ACHIEVES 44.0% CONFIRMED ORR VS 21.4% WITH PEMBROLIZUMAB ALONE

Reuters·05/11/2026 12:00:13

Please log in to view news